She recently served as Chief Executive Officer at Zentalis Pharmaceuticals (2022-2024) and holds educational credentials from Duke University, including a Bachelor’s degree in Bioethics/Medical Ethics and completion of the Medical Oncology Residency Program at Duke University School of Medicine.
